Metraipolis › archive › dc_c93afe34f0eb

Successful Treatment of Nivolumab Plus Ipilimumab After Progression on Durvalumab Plus Tremelimumab in Advanced Hepatocellular Carcinoma: A Case Report — Europe PMC PMID:41446458

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41446458
DOI
10.7759/cureus.97530
License (as archived)
solo-consultazione
Archived
2026-11-08T08:11:00.866Z
SHA-256 of the archived text
b94f54bb3b36476e41c17ea960d52fa5f7b5a7125bf9257e3f370b44a6d82dd2
Stable URL of this page
https://metraipolis.com/documento/dc_c93afe34f0eb

How to cite

Successful Treatment of Nivolumab Plus Ipilimumab After Progression on Durvalumab Plus Tremelimumab in Advanced Hepatocellular Carcinoma: A Case Report — Europe PMC PMID:41446458 — Europe PMC (en), https://europepmc.org/article/MED/41446458 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c93afe34f0eb (Metraipolis archive dc_c93afe34f0eb, sha256 b94f54bb3b36476e41c17ea960d52fa5f7b5a7125bf9257e3f370b44a6d82dd2)
BibTeX
@misc{dcc93afe34f0eb,
  title = {Successful Treatment of Nivolumab Plus Ipilimumab After Progression on Durvalumab Plus Tremelimumab in Advanced Hepatocellular Carcinoma: A Case Report — Europe PMC PMID:41446458},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41446458},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c93afe34f0eb; sha256 b94f54bb3b36476e41c17ea960d52fa5f7b5a7125bf9257e3f370b44a6d82dd2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41446458. Agents can read the archived copy with the MCP tool read_document.